Business Context and Reporting Period
This Form 8-K Current Report was filed by Biocardia, Inc. on November 24, 2025. The report discloses a corporate governance event under Item 8.01 (Other Events) regarding a senior management appointment.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
There are no financial material changes reported in this filing. The sole material event is the appointment of Farhan Shahab as Vice President of Quality, effective November 24, 2025.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of risks and contingencies. The press release attached as Exhibit 99.1 is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the professional background and qualifications of Farhan Shahab in the context of Biocardia's quality assurance needs.
- Confirm the effective date of the appointment and any potential impact on ongoing regulatory submissions or clinical trials.
- Review the attached press release (Exhibit 99.1) for additional context not summarized in the 8-K body.